
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $279.5M | -- | -- | $0.90 | -- |
07/30/2025 | Q2 | $263.4M | -- | -- | $0.71 | -- |
05/06/2025 | Q1 | $246.8M | $256M | -$0.44 | $0.58 | -$1.02 |
02/26/2025 | Q4 | $290.4M | $299M | $0.75 | $0.72 | $0.04 |
11/06/2024 | Q3 | $270.9M | $273.6M | $0.63 | $0.60 | $0.03 |
07/31/2024 | Q2 | $256.4M | $266M | -$0.16 | $0.64 | -$0.80 |
05/08/2024 | Q1 | $236.5M | $241.5M | -$0.42 | $0.72 | -$1.14 |
03/06/2024 | Q4 | $234.5M | $235.3M | $0.74 | $0.80 | -$0.06 |
11/01/2023 | Q3 | -- | -- | $0.63 | $0.76 | -$0.13 |
07/26/2023 | Q2 | -- | -- | $0.68 | $0.78 | -$0.10 |
05/01/2023 | Q1 | -- | -- | $0.71 | $0.63 | $0.09 |
03/08/2023 | Q4 | -- | -- | $0.38 | $0.75 | -$0.37 |
10/26/2022 | Q3 | -- | -- | $0.73 | $0.70 | $0.04 |
07/27/2022 | Q2 | -- | -- | $0.59 | $0.60 | -$0.01 |
04/27/2022 | Q1 | -- | -- | $0.49 | $0.54 | -$0.05 |
03/09/2022 | Q4 | -- | -- | $0.49 | $0.76 | -$0.27 |
10/27/2021 | Q3 | -- | -- | $0.71 | $0.73 | -$0.02 |
07/28/2021 | Q2 | -- | -- | -$0.97 | $0.55 | -$1.52 |
04/28/2021 | Q1 | -- | -- | $0.42 | $0.35 | $0.07 |
03/04/2021 | Q4 | -- | -- | $0.54 | $0.52 | $0.02 |
10/28/2020 | Q3 | -- | -- | $0.73 | $0.60 | $0.14 |
07/29/2020 | Q2 | -- | -- | -$2.05 | $0.05 | -$2.10 |
04/30/2020 | Q1 | -- | -- | $0.30 | -- | -- |
02/27/2020 | Q4 | -- | -- | $0.90 | -- | -- |
10/29/2019 | Q3 | -- | -- | $0.95 | -- | -- |
07/30/2019 | Q2 | -- | -- | $0.89 | -- | -- |
05/02/2019 | Q1 | -- | -- | $0.60 | -- | -- |
02/28/2019 | Q4 | -- | -- | $0.84 | -- | -- |
10/30/2018 | Q3 | -- | -- | $0.92 | -- | -- |
07/26/2018 | Q2 | -- | -- | $0.80 | -- | -- |
04/30/2018 | Q1 | -- | -- | $0.65 | -- | -- |
03/01/2018 | Q4 | -- | -- | $1.60 | -- | -- |
10/26/2017 | Q3 | -- | -- | $0.61 | -- | -- |
07/27/2017 | Q2 | -- | -- | $0.72 | -- | -- |
04/27/2017 | Q1 | -- | -- | $0.67 | -- | -- |
02/27/2017 | Q4 | -- | -- | $0.66 | -- | -- |
10/26/2016 | Q3 | -- | -- | $0.65 | -- | -- |
07/28/2016 | Q2 | -- | -- | $0.55 | -- | -- |
04/28/2016 | Q1 | -- | -- | $0.61 | -- | -- |
02/25/2016 | Q4 | -- | -- | $0.72 | -- | -- |
10/29/2015 | Q3 | -- | -- | $0.60 | -- | -- |
VSE reported $256M worth of top line sales in its most recent quarter.
VSE announced earnings per share of -$0.44 which represents a miss of analyst forecast a $0.58 per share.
VSE reported $26.8M that represents $1.29 per share over the last quarter.
VSE's earnings are forecast to grow from $0.85 per share to $2.93 per share next year representing an increase of 313.73%.
VSE's next earnings date is July 30, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.